[PHARMA] QoQ Cumulative Quarter Result on 31-Mar-2017 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Mar-2017 [#1]
Profit Trend
QoQ- -58.5%
YoY- 2.96%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 2,323,960 1,710,764 1,136,261 618,294 2,189,022 1,606,206 1,090,991 65.32%
PBT 73,064 53,198 37,927 27,777 72,017 67,948 48,025 32.17%
Tax -17,977 -20,299 -8,918 -8,519 -26,158 -21,189 -13,914 18.56%
NP 55,087 32,899 29,009 19,258 45,859 46,759 34,111 37.52%
-
NP to SH 53,823 32,023 28,443 18,923 45,599 46,435 33,374 37.40%
-
Tax Rate 24.60% 38.16% 23.51% 30.67% 36.32% 31.18% 28.97% -
Total Cost 2,268,873 1,677,865 1,107,252 599,036 2,143,163 1,559,447 1,056,880 66.18%
-
Net Worth 526,888 531,892 541,894 544,360 531,169 530,907 524,041 0.36%
Dividend
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Div 49,314 33,729 20,742 10,368 41,457 33,667 23,302 64.61%
Div Payout % 91.62% 105.33% 72.93% 54.79% 90.92% 72.50% 69.82% -
Equity
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Net Worth 526,888 531,892 541,894 544,360 531,169 530,907 524,041 0.36%
NOSH 259,821 259,821 259,279 259,219 259,377 258,979 258,913 0.23%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 2.37% 1.92% 2.55% 3.11% 2.09% 2.91% 3.13% -
ROE 10.22% 6.02% 5.25% 3.48% 8.58% 8.75% 6.37% -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 895.38 659.36 438.24 238.52 844.83 620.21 421.37 65.05%
EPS 20.74 12.34 10.97 7.30 17.60 17.93 12.89 37.19%
DPS 19.00 13.00 8.00 4.00 16.00 13.00 9.00 64.34%
NAPS 2.03 2.05 2.09 2.10 2.05 2.05 2.024 0.19%
Adjusted Per Share Value based on latest NOSH - 259,219
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 161.25 118.70 78.84 42.90 151.89 111.45 75.70 65.32%
EPS 3.73 2.22 1.97 1.31 3.16 3.22 2.32 37.12%
DPS 3.42 2.34 1.44 0.72 2.88 2.34 1.62 64.34%
NAPS 0.3656 0.3691 0.376 0.3777 0.3686 0.3684 0.3636 0.36%
Price Multiplier on Financial Quarter End Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 -
Price 4.60 4.14 4.58 4.89 5.30 5.58 5.50 -
P/RPS 0.51 0.63 1.05 2.05 0.63 0.90 1.31 -46.59%
P/EPS 22.18 33.54 41.75 66.99 30.12 31.12 42.67 -35.27%
EY 4.51 2.98 2.40 1.49 3.32 3.21 2.34 54.68%
DY 4.13 3.14 1.75 0.82 3.02 2.33 1.64 84.78%
P/NAPS 2.27 2.02 2.19 2.33 2.59 2.72 2.72 -11.32%
Price Multiplier on Announcement Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 27/02/18 15/11/17 16/08/17 16/05/17 21/02/17 21/11/16 19/08/16 -
Price 4.04 3.82 4.19 4.72 5.12 5.70 5.62 -
P/RPS 0.45 0.58 0.96 1.98 0.61 0.92 1.33 -51.34%
P/EPS 19.48 30.95 38.20 64.66 29.09 31.79 43.60 -41.47%
EY 5.13 3.23 2.62 1.55 3.44 3.15 2.29 70.95%
DY 4.70 3.40 1.91 0.85 3.13 2.28 1.60 104.70%
P/NAPS 1.99 1.86 2.00 2.25 2.50 2.78 2.78 -19.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment